8don MSN
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...
The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...
1d
EatingWell on MSNYour Dementia Risk May Be Increased by Another Disease Diagnosis—Here’s How to Prevent ItIf you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...
In the 1980s, researchers studying the autopsied brains of people with Alzheimer’s discovered that they were clogged with sticky plaques made from beta amyloid proteins and toxic tangles made of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results